Adhera Therapeutics, Inc.
ATRX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
44.07k
▼-37.93k▼-46.25%
3 Months ChangeLiabilities
26.36M
▲3.49M▲15.26%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-01-18
Form 8-K
ID: 0001493152-24-002907
2024-01-16
Form 8-K
ID: 0001493152-24-002422
2023-11-29
Form 8-K
ID: 0001493152-23-043045
2023-11-20
Form 10-Q
ID: 0001493152-23-042138
2023-10-12
Form 8-K
ID: 0001493152-23-037063
2023-08-21
Form 10-Q
ID: 0001493152-23-029594
2023-06-29
Form 8-K
ID: 0001493152-23-022945
2023-05-22
Form 10-Q
ID: 0001493152-23-018516
2023-05-05
Form 8-K
ID: 0001493152-23-015579
2023-05-04
Form 8-K
ID: 0001493152-23-015429